natgillin/translations-raw huggingface dataset:
I studiet TAX 316 blev alopeci, der persisterede ind i follow-up perioden efter endt kemoterapi, rapporteret hos 687 ud af 744 TAC-patienter og 645 ud af 736 FAC-patienter.
In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 of 744 TAC patients and 645 of 736 FAC patients.
I studiet TAX 316 blev alopeci, der persisterede ind i follow-up perioden efter endt kemoterapi, rapporteret hos 687 ud af 744 TAC-patienter og 645 ud af 736 FAC-patienter.
In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 of 744 TAC patients and 645 of 736FAC patients.
I studiet TAX 316 blev alopeci, der persisterede ind i followup perioden efter endt kemoterapi, rapporteret hos 687 ud af 744 TAC-patienter og hos 645 ud af 736 FAC-patienter.
In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 of 744 TAC patients and 645 of 736 FAC patients.
I studiet TAX 316 blev alopeci, der persisterede ind i followup-perioden efter endt kemoterapi, rapporteret hos 687 ud af 744 TAC-patienter og hos 645 ud af 736 FAC-patienter.
In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 TAC patients and 645 FAC patients.
I studiet TAX 316 blev alopeci, der vedvarede ind i opfølgningsperioden efter endt kemoterapi, rapporteret hos 687 ud af 744 TAC-patienter og hos 645 ud af 736 FAC-patienter.
In study TAX316, alopecia persisting into the follow-up period after the end of chemotherapy was reported in 687 of 744 TAC patients and 645 of 736 FAC patients.
I studiet TAX 316 fortsatte perifert ødem fortsatte hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen of hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen..
In study TAX316, peripheral oedema was observed to be ongoing in 19 patients out of the 119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX316, peripheral oedema was observed to be ongoing in 19 patients out of the 119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX 316, peripheral oedema was observed to be ongoing in 19 patients out of the 119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX316, peripheral oedema was observed to be ongoing in 19 patients out of the 119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX316, peripheral oedema was observed to be ongoing in 19 patients out of the 119 patients with peripheral oedema in theTAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX316, peripheral oedema was observed to be ongoing in 19 patients out of the119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 fortsatte perifert ødem hos 19 patienter ud af de 119 patienter med perifert ødem i TAC-armen og hos 4 patienter ud af de 23 patienter med perifert ødem i FAC-armen.
In study TAX316, peripheral oedema was observed to be ongoing in19 patients out of the 119 patients with peripheral oedema in the TAC arm and 4 patients out of the 23 patients with peripheral oedema in the FAC arm.
I studiet TAX 316 oplevede 26 patienter (3,5 %) i TAC-armen og 17 patinter (2,3 %) i FAC-armen kongestivt hjertesvigt.
In study TAX316, 26 patients (3.5%) in the TAC arm and 17 patients (2.3%) in the FAC arm experienced congestive heart failure.
I studiet TAX 316 oplevede 26 patienter (3,5%) i TAC-armen og 17 patienter (2,3%) i FAC- armen kongestivt hjertesvigt.
In study TAX316, 26 patients (3.5%) in the TAC arm and 17 patients (2.3%) in the FAC arm experienced congestive heart failure.
I studiet var begge apixabandoser statistisk superior til placebo i det primære endepunkt symptomatisk, recidiverende VTE (ikke-dødelig DVT eller ikke-dødelig LE) eller død uanset årsag (se tabel 10).
In the study, both doses of apixaban were statistically superior to placebo in the primary endpoint of symptomatic, recurrent VTE (nonfatal DVT or nonfatal PE) or all-cause death (see Table 10).
I studiet var begge apixabandoser statistisk superior til placebo i det primære endepunkt symptomatisk, recidiverende VTE (ikke-dødelig DVT eller ikke-dødelig LE) eller død uanset årsag (se tabel 12).
In the study, both doses of apixaban were statistically superior to placebo in the primary endpoint of symptomatic, recurrent VTE (nonfatal DVT or nonfatal PE) or all-cause death (see Table 12).
I studiet var disse symptomer almindelige og blev set hos 2 af 106 behandlede hunde.
In the study these reactions were common (seen in 2 of 106 treated dogs).
I studiet vedrørende nyligt diagnosticeret CML i kronisk fase omfattede dasatinib-relaterede væskeretentionsbivirkninger efter mindst 60 måneders opfølgning pleuraeffusion (28%), superficielt ødem (14%), pulmonal hypertension (5%), generaliseret ødem (4%) og perikardie-effusion (4%).
In the newly diagnosed chronic phase CML study after a minimum of 60 months follow-up, dasatinib-related fluid retention adverse reactions included pleural effusion (28%), superficial oedema (14%), pulmonary hypertension (5%), generalised oedema (4%), and pericardial effusion (4%).
I studiet vs. insulin glargin, blev administration af Levemir tilladt én eller to gange daglig, hvorimod insulin glargin blev administreret én gang daglig.
In the study versus insulin glargine, Levemir was allowed to be administered once or twice daily whereas insulin glargine was to be administered once a day, 55% of the Levemir treated patients completed the
I studiet ”Prevention Regimen For Effectively avoiding Second Strokes” (PRoFESS) hos patienter på 50 år og ældre, som for nylig har oplevet stroke, blev der observeret en øget incidens af sepsis hos patienter behandlet med telmisartan sammenlignet med placebo, 0,70% vs.
In the "Prevention Regimen For Effectively avoiding Second Strokes" (PRoFESS) trial in patients 50 years and older, who recently experienced stroke, an increased incidence of sepsis was noted for telmisartan compared with placebo, 0.70% vs.
I studiet, der sammenlignede Levemir med insulin degludec, var frekvensen af hyperglykæmiske episoder med ketose signifikant højere for Levemir, respektivt 1,09 og 0,68 episoder per patient-eksponeringsår.
In the trial comparing Levemir vs insulin degludec, the rate of hyperglycaemic episodes with ketosis was significantly higher for Levemir, 1.09 and 0.68 episodes per patient-year of exposure, respectively.
I studiet, som blev kørt med unge dyr behandlet over hele udviklingsperioden svarende til spædbarnsalder, barndom og pubertet, blev der dog ikke observeret effekter på fertiliteten hos hverken hanner eller hunner (Se pkt.
However, in the study conducted in juvenile animals treated all over the development period corresponding to infancy, childhood and adolescence, no effect on male and female fertilities was observed (See section 4.6).
I studiets 2. år blev kvinderne fra den oprindelige Preotact- gruppe randomiseret til enten alendronat- eller placebobehandling og kvinderne fra de 2 andre grupper fik alendronat.
In the second year of the study women in the original Preotact group were randomly assigned to receive either alendronate or matching placebo, and women in the other two groups received alendronate.
I studiets forløb forblev den rapporterede incidens af bivirkninger generelt stabil eller reduceret.
Over the course of the study, the reported incidence of AEs generally remained stable or declined.
I studiets randomiserede del blev patienterne randomiseret efter 3 alderskohortestrata (2:1) til eltrombopag (n = 45) eller placebo (n = 22).
During the randomised period of the study, subjects were randomised by 3 age cohort strata (2:1) to eltrombopag (n=45) or placebo (n=22).
I større doser virker ritonavir som en "proteasehæmmer".
At higher doses, ritonavir acts as a ‘protease inhibitor’.
I størstedelen af tilfældene var opkastningen forbigående, mild og krævede ikke symptomatisk behandling.
In the majority of cases, vomiting was transient, mild and did not require symptomatic treatment.
I sub-gruppen af cytokin-behandlede patienter, havde størstedelen (75 %) fået interferon-baseret behandling.
In the cytokine-pre-treated subgroup, the majority (75 %) had received interferon based treatment.
I sub-studiets periode på 12 uger med den fyldte pen optrådte der ingen dødsfald eller relaterede alvorlige bivirkninger.
During the 12-week pre-filled pen period of the sub-study, there were no deaths or related SAEs.
I subgruppeanalyse af samlet overlevelse hos patienter <65 år og ≥65 år der fik ZALTRAP/FOLFIRI- regimet, observeredes en fordel svarende til den for den samlede population.
In sub-group analysis of overall survival, a benefit consistent with the overall population was observed in patients <65 years old and ≥65 years old who received the ZALTRAP/FOLFIRI regimen.
I subgruppeanalyserne af tidligere brug af cisplatin i forhold til BSC for progressionsfri overlevelse (PFS) var resultaterne: HR (95% CI) = [0,55 (0,34-0,89); p=0,0129] ved fravær af tidligere brug af cisplatin, og HR (95% CI) = [0,64 (0,48-0,85); p=0,0040] ved forekomst af tidligere brug af cisplatin.
In the subgroup analyses of prior cisplatin use versus BSC for progression free survival (PFS), the results were: HR (95% CI) = [0.55 (0.34 – 0.89); p=0.0129] in the absence of prior cisplatin, and a HR (95% CI) = [0.64 (0.48 – 0.85); p=0.0040] in the presence of prior cisplatin.
I subgruppen af patienter med udekterbar sygdom (n=205) var hazard ratio for progressionsfri overlevelse og samlet overlevelse henholdsvis 0,91 (95% konfidensinterval 0,59; 1,42) og 0,96 (95% konfidensinterval 0,54; 1,68), på basis af vurderinger fra en uafhængig komité.
In the subgroup of patients with non-measurable disease (n=205), based on IRC assessments, the hazard ratios for PFS and OS were 0.91 (95% CI: 0.59, 1.42) and 0.96 (95% CI: 0.54, 1.68), respectively.
I subgrupper bestående af kvinder og sorte patienter, henholdsvis 32 % og 26 % af den samlede forsøgspopulation, sås der ingen evidens for nyrefordel, selvom sikkerhedsintervallerne ikke udelukker det.
In the female and black subgroups which represented 32 % and 26 % of the overall study population respectively, a renal benefit was not evident, although the confidence intervals do not exclude it.
I subgrupper bestående af kvinder og sorte patienter, henholdsvis 32% og 26% af den samlede forsøgspopulation, sås der ingen evidens for nyrefordel, selvom sikkerhedsintervallerne ikke udelukker det.
In the female and black subgroups which represented 32% and 26% of the overall study population respectively, a renal benefit was not evident, although the confidence intervals do not exclude it.
I subkroniske og kroniske toksikologistudier er observeret hyperplasi i galdeblære, de hepatiske galdegange og i bugspytkirtlens udførselsgange.
Hyperplasia in the gall bladder, hepatic biliary ducts, and pancreatic ducts were observed in subchronic and chronic toxicology studies.
I supplerende forsøg, hvor ikke-selektive NSAID blev anvendt som sammenligningsprodukter, blev ca.
In additional studies using non-selective NSAID comparators, approximately
I syv publikationer var der rapporteret om sytten (17) patienter med GIST (med eller uden Kit og PDGFR- mutationer).
Seventeen (17) patients with GIST (with or without Kit and PDGFR mutations) were reported in 7 publications.
I så fald angiv venligst typen, og hvornår de sidst blev taget.
If so, please indicate type and when last taken.
I så fald angiv venligst, hvornår behandlingen ophørte.
If so, please indicate when treatment ended
I så fald bedes man venligst angive typen, og hvornår de sidst blev taget.
If so, please indicate type and when last taken
I så fald bliver den fulde dosis ikke leveret, og du skal kontrollere dit blodsukkerniveau hyppigere. tæl langsomt til 6.
If so, the full dose will not be delivered, and you should increase the frequency of checking your blood sugar level.
I så fald bør administration af insulin midlertidigt stoppes og næste insulindosis passende justeres.
Insulin administration should be temporarily stopped and the next dose of insulin adjusted appropriately.
I så fald bør der foretages en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Corbilta, se afsnittet ”Hvis du holder op med at tage Corbilta”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Corbilta, see section 'If you stop taking Corbilta'.
I så fald bør der foretages en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Levodopa/Carbidopa/Entacapone Orion, se afsnittet ”Hvis du holder op med at tage Levodopa/Carbidopa/Entacapone Orion”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Levodopa/Carbidopa/Entacapone Orion, see section 'If you stop taking Levodopa/Carbidopa/Entacapone Orion'.
I så fald bør der foretages en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Stalevo, se afsnittet ”Hvis du holder op med at tage Stalevo”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Stalevo, see section 'If you stop taking Stalevo'.
I så fald bør Deres læge overvåge Deres nyrefunktion regelmæssigt.
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
I så fald bør det overvejes at foretage en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Corbilta, se afsnittet ”Hvis du holder op med at tage Corbilta”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Corbilta, see section 'If you stop taking Corbilta'.
I så fald bør det overvejes at foretage en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Levodopa/Carbidopa/Entacapone Orion, se afsnittet ”Hvis du holder op med at tage Levodopa/Carbidopa/Entacapone Orion”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Levodopa/Carbidopa/Entacapone Orion, see section 'If you stop taking Levodopa/Carbidopa/Entacapone Orion'.
I så fald bør det overvejes at foretage en generel medicinsk undersøgelse, som bør omfatte leverfunktionen føler behov for at holde op med at bruge Stalevo, se afsnittet ”Hvis du holder op med at tage Stalevo”.
If this happens, a general medical evaluation including liver function should be considered feel the need to stop using Stalevo, see section 'If you stop taking Stalevo'.
I så fald bør det overvejes at give orlistat og antiepileptika på forskellige tidspunkter (se pkt.
Orlistat may decrease the absorption of antiepileptic medicinal products, leading to convulsions.
I så fald bør din læge overvåge din nyrefunktion regelmæssigt.
In this case, monitoring of your kidney function should be performed by your doctor at specified intervals.
I så fald er en individuel risk/benefit-vurdering obligatorisk, og patienten skal monitoreres for QT-forlængelse.
In these situations an individual benefit-risk assessment is mandatory and patients should be monitored for occurrence of QT prolongation.
I så fald er Evoltra måske ikke det rette middel til dig:
Evoltra may not be suitable for you:
I så fald har du ikke modtaget nogen medicin, selv om dosistælleren har bevæget sig fra den oprindelige dosis, du valgte.
In this case - you have not received any medicine - even though the dose counter has moved from the original dose that you have set.
I så fald kan du have en arvelig fejl i blodets størkning; hvis du skal opereres, eller hvis du er sengeliggende i en længere periode på grund af en skade eller sygdom, eller hvis et af dine ben er i gips.
In this case you could have a hereditary blood clotting disorder; if you need to have an operation, or if you are off your feet for a long time because of an injury or illness, or you have your leg in a cast.
I så fald må præparatet ikke anvendes.
In this case, do not use the product.
I så fald skal der være umiddelbar adgang til lægebehandling i tilfælde af, at du får en allergisk reaktion.
This is as long as medical treatment is available straight away, in case you have an allergic reaction
I så fald skal dit barns kaliumniveau i blodet måles.
In this case, your child’s blood potassium level should be measured.
I så fald skal du gennemføre den aktuelle cyklus og fjerne det tredje plaster som planlagt.
You will need to complete the current cycle and remove the third patch on the correct day.
I så fald skulle vaccinationsprogrammet fortsættes med en vaccine, som ikke indeholder en pertussis- komponent.
In these circumstances the vaccination course should be continued with vaccine not containing a pertussis component.
I så fald vil din læge også udskrive medicin, der kan hjælpe med at forebygge denne form for lungebetændelse (PCP). hvis du nogensinde har fået konstateret eller på nuværende tidspunkt har en hepatitis B-infektion.
In this case, your doctor will also prescribe medicine to help you prevent this type of pneumonia (PCP). if you have ever had or might now have a hepatitis B infection.
I så fald vil din læge også udskrive medicin, der kan hjælpe med at forebygge denne form for lungebetændelse. hvis du nogensinde har fået konstateret eller på nuværende tidspunkt har en hepatitis B- infektion.
In this case, your doctor will also prescribe medicine to help you prevent this type of pneumonia (PCP). if you have ever had or might now have a hepatitis B infection.
I så fald vil du få undervisning i, hvordan du skal gøre dette.
In this case you will get training on how to inject Stelara yourself.
I så fald vil maksimal daglig dosis være 3,15 mg.
However, your dose may have to be increased even further.
I så fald vil maksimal daglig dosis være 3,15 mg.
If necessary, your doctor may increase your dose up to a maximum of 3.15 mg of pramipexole a day.
I så fald vil maksimal daglig dosis være 3,3 mg.
However, your dose may have to be increased even further.
I så fald vil maksimal daglig dosis være 3,3 mg.
If necessary, your doctor may increase your tablet dose up to a maximum of 3.3 mg of pramipexole a day.
I så tilfælde bruges det sammen med et andet lægemiddelstof, der kaldes cisplatin.
In this case, it is used with another medicine called cisplatin.
I sådan tilfælde skal det overvejes at afbryde behandlingen med dalbavancin og iværksætte understøttende foranstaltninger sammen med administration af specifik behandling for Clostridium difficile.
In such circumstance, the discontinuation of dalbavancin and the use of supportive measures together with the administration of specific treatment for Clostridium difficile should be considered.
I sådanne situationer kan kontrollen af Deres diabetes kræve meget omhyggelig kontrol, og det kan blive nødvendigt, at De kontakter Deres læge eller diabetessygeplejerske.
In such situations, the management of your diabetes may require a lot of care and you may need to seek advice from your doctor or nurse.
I sådanne situationer vil din kirurg blive underrettet og vil muligvis være nødt til at vælge en alternativ behandling til dig.
In such situations, your surgeon will be informed and might have to select an alternative treatment for you.
I sådanne tilfælde anbefales det at afbryde behandlingen med Raptiva.
In such cases, it is recommended to discontinue treatment with Raptiva.
I sådanne tilfælde anbefales det at kontakte et center, der er specialiseret i behandling af hæmofili.
In such cases, it is recommended that a specialised haemophilia centre be contacted.
I sådanne tilfælde anbefales det at kontakte et specialcenter for hæmofili.
In such cases, it is recommended that a specialised haemophilia centre be contacted.
I sådanne tilfælde anbefales det, at der tages kontakt til en specialafdeling for hæmofili.
In such cases, it is recommended that a specialised haemophilia centre be contacted.
I sådanne tilfælde anbefales lokal behandling, men mundskyllevæsker indeholdende alkohol, hydrogenperoxid, iod eller timianekstrakt skal undgås, da de kan forværre tilstanden.
In such cases topical treatments are recommended, but mouthwashes containing alcohol, hydrogen peroxide, iodine and thyme derivatives should be avoided as they may exacerbate the condition.
I sådanne tilfælde anbefales lokal behandling, men mundskyllevæsker indeholdende alkohol, peroxid, iod eller timianekstrakt skal undgås, da de kan forværre tilstanden.
In such cases topical treatments are recommended, but mouthwashes containing alcohol, peroxide, iodine and thyme derivatives should be avoided as they may exacerbate the condition.
I sådanne tilfælde bør behandlingen stoppes.
If this occurs, treatment should be stopped.
I sådanne tilfælde bør der gives korrekt symptomatisk behandling.
In such cases, an appropriate symptomatic treatment should be provided.
I sådanne tilfælde bør det potentielle risk/benefit- forhold vurderes nøje, før vaccinationen gives.
The potential risk- to-benefit ratio should be carefully evaluated before considering vaccination in such cases.
I sådanne tilfælde bør man kontakte en specialafdeling for hæmofili.
In such cases, a specialised haemophilia centre should be contacted.
I sådanne tilfælde bør man overveje behandling med antihistaminer i.v.
In such cases treatment with antihistamines i.v. should be considered.
I sådanne tilfælde bør patienten ikke føre motorkøretøj eller betjene maskiner.
In such cases, patients should refrain from driving cars and using machines.
I sådanne tilfælde bør startdosis være 150 mg hver anden dag.
In such cases, the starting dose should be 150 mg every other day.
I sådanne tilfælde bør thyroideafunktionen undersøges for at kunne identificere en mulig nedsat thyroideafunktion forbundet med mitotanbehandling.
In such cases, thyroid function should be investigated in order to identify a possible thyroid impairment linked to mitotane treatment.
I sådanne tilfælde er behandling med Topotecan Actavis kombineret med medicin, der indeholder cisplatin.
In this case Topotecan Actavis treatment is combined with medicines containing cisplatin.
I sådanne tilfælde kan du også opleve allergiske reaktioner over for NexoBrid, du er allergisk over for papain, latex, bistik eller pollen fra oliventræer.
If so, you may also experience allergic reactions to NexoBrid; you are allergic to papain, latex, bee stings, or olive tree pollen.
I sådanne tilfælde kan du også opleve allergiske reaktioner over for NexoBrid, du har nyre- eller leverproblemer.
If so, you may also experience allergic reactions to NexoBrid; you have kidney or liver problems.
I sådanne tilfælde kan du udvikle alvorlig hypoglykæmi (og endda besvime), før du selv bliver klar over problemet.
If this happens, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem.